Roflumilast Tablets – Product Highlights
Active Ingredient: Roflumilast
Strength: 500 mcg
Dosage Form: Tablet
Therapeutic Category: Respiratory / COPD medicine
Pharmacological Class: Selective PDE-4 inhibitor
Route: Oral
Typical regulated market status: Prescription medicine
Roflumilast is intended for maintenance treatment, not for immediate relief of acute bronchospasm. It is generally used as an add-on to appropriate bronchodilator treatment in selected patients.
What is Roflumilast Tablet Used For?
Roflumilast is used in appropriate adult patients with severe COPD associated with chronic bronchitis and a history of frequent exacerbations.
It works by inhibiting the PDE-4 enzyme, helping reduce inflammatory activity associated with COPD. It is not a conventional bronchodilator and should not be relied upon for rapid relief of an acute breathing attack.
Potential Benefits / Advantages
Helps reduce the risk of COPD exacerbations in appropriate patients.
Provides an oral maintenance-treatment option.
PDE-4 inhibition targets inflammatory pathways involved in COPD.
Can be used as an add-on to bronchodilator therapy when clinically appropriate.
Once-daily administration is used for the approved 500 mcg COPD regimen.
Roflumilast Tablet Disadvantages & Possible Side Effects
Roflumilast may not be suitable for every patient. Common adverse reactions reported with roflumilast include:
Diarrhea
Weight loss
Nausea
Headache
Back pain
Insomnia
Dizziness
Decreased appetite
FDA labeling also contains warnings concerning psychiatric symptoms and clinically significant weight loss.
Patients should be evaluated by a qualified healthcare professional before treatment. Roflumilast is contraindicated in moderate-to-severe hepatic impairment in the FDA labeling, and drug interactions and individual patient factors should be reviewed before prescribing.
Roflumilast 500 mcg – Important Medical Note
Roflumilast is not a rescue medicine for sudden breathing difficulty. Patients experiencing acute bronchospasm require appropriate emergency/rescue treatment as directed by their healthcare professional.
The 500 mcg tablet is the established COPD treatment strength in the U.S. FDA labeling. In the EU, Daxas product information describes a 250 mcg starting dose followed by 500 mcg daily to improve tolerability; local product information and regulatory requirements should always be followed.
Roflumilast Tablet Exporter from India
Cordium Pharmaceuticals Pvt. Ltd. welcomes legitimate B2B enquiries for pharmaceutical sourcing and international supply.
We aim to support:
Pharmaceutical distributors
Importers
Wholesalers
Hospitals and healthcare procurement teams
Licensed pharmacies
Pharmaceutical trading companies
Institutional buyers
Healthcare supply partners
All pharmaceutical supply should comply with applicable Indian export requirements and the destination country's registration, import, prescription and regulatory requirements.
Roflumilast Tablet Supply – International Market Focus
Singapore
Target cities:
Singapore City / Central Region, Jurong, Woodlands, Tampines, Bedok
Suggested search intent:
Roflumilast 500 mcg Singapore, Roflumilast tablets Singapore, Roflumilast supplier Singapore, Roflumilast pharmaceutical exporter Singapore, COPD medicine supplier Singapore
Malaysia
Target cities:
Kuala Lumpur, Petaling Jaya, Shah Alam, Johor Bahru, Penang, George Town
Suggested search intent:
Roflumilast 500 mcg Malaysia, Roflumilast tablets Malaysia, Roflumilast supplier Kuala Lumpur, Roflumilast exporter Malaysia, COPD medicine supplier Malaysia
Kenya
Target cities:
Nairobi, Mombasa, Kisumu, Nakuru, Eldoret
Suggested search intent:
Roflumilast 500 mcg Kenya, Roflumilast tablets Kenya, Roflumilast supplier Nairobi, Roflumilast exporter Kenya, COPD medicine supplier Kenya
United States
Target cities:
New York City, Los Angeles, Houston, Chicago, Miami, Dallas, Atlanta
Suggested search intent:
Roflumilast 500 mcg USA, Roflumilast tablets USA, generic roflumilast supplier USA, roflumilast pharmaceutical exporter, COPD medicine supplier USA
United Kingdom
Target cities:
London, Birmingham, Manchester, Liverpool, Leeds, Glasgow
Suggested search intent:
Roflumilast 500 mcg UK, Roflumilast tablets UK, Roflumilast supplier London, Roflumilast exporter UK, COPD medicine supplier UK
United Arab Emirates
Target cities:
Dubai, Abu Dhabi, Sharjah, Ajman, Al Ain
Suggested search intent:
Roflumilast 500 mcg UAE, Roflumilast tablets UAE, Roflumilast supplier Dubai, Roflumilast exporter UAE, COPD medicine supplier UAE
South Africa
Target cities:
Johannesburg, Cape Town, Durban, Pretoria, Gqeberha
Suggested search intent:
Roflumilast 500 mcg South Africa, Roflumilast tablets South Africa, Roflumilast supplier Johannesburg, Roflumilast exporter South Africa, COPD medicine supplier South Africa
Why Choose Cordium Pharmaceuticals?
Trusted Pharmaceutical Export Partner
Cordium Pharmaceuticals Pvt. Ltd. is focused on international pharmaceutical sourcing and export requirements.
B2B-Oriented Supply
We work with eligible international buyers, distributors, wholesalers, healthcare businesses and institutional procurement teams.
Export-Focused Documentation
We understand the importance of appropriate commercial and pharmaceutical documentation for international transactions.
Global Market Support
Our team can support enquiries from buyers across Asia, Africa, the Middle East, Europe and other international markets, subject to applicable regulations.
Professional Enquiry Support
For product availability, commercial requirements, packaging, documentation and export enquiries, contact our team directly.
Roflumilast Tablet Export Enquiry
Cordium Pharmaceuticals Pvt. Ltd.
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com